Stocks · News reference
Filed: 2026-09-15 AccNo: 0001104659-26-107911 Size: 707 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Despite elevated Treasury yields near 5.3%, three financial stocks remain attractive high-yield investments: Ares Capital (10% yield, rate-resistant BDC model), Brookfield Asset Management (4.5% yield, asset-light fee-based model), and Strategy's Strife preferred shares (10% fixed dividend, senior preferred stock backed by Bitcoin holdings).
The Federal Reserve raised rates by 25 basis points with more hikes expected, creating headwinds for high-yield dividend stocks. However, Ares Capital (ARCC), yielding over 10%, could benefit from rising rates since 71% of its investment portfolio is in floating-rate debt, which generates more income as rates rise. The company has a 17-year track record of maintaining stable and growing dividends through previous rate-hike cycles, making it an attractive buying opportunity despite near-term stock price pressure.
An official report on September 18, 2026 reveals Representative Pete Sessions's recent sale of AbbVie (NYSE:ABBV) stock, valued between $30,002 and $100,000. The transaction took place on September 14, 2026, as per